Frank James S 4
Accession 0001144204-10-008501
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:06 PM ET
Size
18.7 KB
Accession
0001144204-10-008501
Insider Transaction Report
- Sale
Common Stock, par value $0.01
2010-02-11$16.19/sh−2,071$33,524→ 207,087 total - Sale
Common Stock, par value $0.01
2010-02-12$16.07/sh−2,820$45,312→ 204,267 total - Sale
Common Stock, par value $0.01
2010-02-11$15.98/sh−500$7,990→ 209,658 total - Sale
Common Stock, par value $0.01
2010-02-11$16.02/sh−500$8,009→ 209,158 total - Sale
Common Stock, par value $0.01
2010-02-16$15.74/sh−50,109$788,666→ 154,158 total
- 99,367(indirect: By Arcadia Opportunity Master Fund, Ltd.)
Common Stock, par value $0.01
- Sale
Common Stock, par value $0.01
2010-02-11$16.02/sh−500$8,009→ 209,158 total - Sale
Common Stock, par value $0.01
2010-02-12$16.07/sh−2,820$45,312→ 204,267 total - Sale
Common Stock, par value $0.01
2010-02-11$15.98/sh−500$7,990→ 209,658 total - Sale
Common Stock, par value $0.01
2010-02-11$16.19/sh−2,071$33,524→ 207,087 total - Sale
Common Stock, par value $0.01
2010-02-16$15.74/sh−50,109$788,666→ 154,158 total
- 99,367(indirect: By Arcadia Opportunity Master Fund, Ltd.)
Common Stock, par value $0.01
- Sale
Common Stock, par value $0.01
2010-02-12$16.07/sh−2,820$45,312→ 204,267 total - Sale
Common Stock, par value $0.01
2010-02-11$16.19/sh−2,071$33,524→ 207,087 total - Sale
Common Stock, par value $0.01
2010-02-11$15.98/sh−500$7,990→ 209,658 total - Sale
Common Stock, par value $0.01
2010-02-11$16.02/sh−500$8,009→ 209,158 total - Sale
Common Stock, par value $0.01
2010-02-16$15.74/sh−50,109$788,666→ 154,158 total
- 99,367(indirect: By Arcadia Opportunity Master Fund, Ltd.)
Common Stock, par value $0.01
- Sale
Common Stock, par value $0.01
2010-02-11$15.98/sh−500$7,990→ 209,658 total - Sale
Common Stock, par value $0.01
2010-02-11$16.02/sh−500$8,009→ 209,158 total - Sale
Common Stock, par value $0.01
2010-02-16$15.74/sh−50,109$788,666→ 154,158 total - Sale
Common Stock, par value $0.01
2010-02-11$16.19/sh−2,071$33,524→ 207,087 total - Sale
Common Stock, par value $0.01
2010-02-12$16.07/sh−2,820$45,312→ 204,267 total
- 99,367(indirect: By Arcadia Opportunity Master Fund, Ltd.)
Common Stock, par value $0.01
- Sale
Common Stock, par value $0.01
2010-02-12$16.07/sh−2,820$45,312→ 204,267 total - Sale
Common Stock, par value $0.01
2010-02-11$16.19/sh−2,071$33,524→ 207,087 total - Sale
Common Stock, par value $0.01
2010-02-16$15.74/sh−50,109$788,666→ 154,158 total - Sale
Common Stock, par value $0.01
2010-02-11$15.98/sh−500$7,990→ 209,658 total - Sale
Common Stock, par value $0.01
2010-02-11$16.02/sh−500$8,009→ 209,158 total
- 99,367(indirect: By Arcadia Opportunity Master Fund, Ltd.)
Common Stock, par value $0.01
Footnotes (3)
- [F1]These securities are owned solely and directly by Mr. James Frank, who is a member of a "group" with the other Reporting Persons for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- [F2]These securities are owned solely and directly by Arcadia Opportunity Master Fund, Ltd. (the "Fund"), which is a member of a "group" with Mr. James Frank for purposes of Section 13(d) of the Exchange Act. Arcadia Capital Advisors, LLC, a Delaware limited liability company, is the investment manager ("Investment Manager") of the Fund and has discretionary investment authority over the Fund's assets. The managing member of the Investment Manager is M.D. Sass FinStrat Arcadia Capital Holdings, LLC (the "Managing Member").
- [F3]Richard Rofe is the managing director and a principal of the Investment Manager and serves as the portfolio manager of the Fund, subject to the oversight of the Managing Member and the Investment Manager. All Reporting Persons (other than the Fund) disclaim beneficial ownership of these securities, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Documents
Issuer
CPEX Pharmaceuticals, Inc.
CIK 0001418919
Related Parties
1- filerCIK 0001480078
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 9:06 PM ET
- Size
- 18.7 KB